VRTXVertex Pharmaceuticals Incorporated
Healthcare · BiotechnologyNasdaqStockMkt cap $134.1B
Disclosed trades
22
1 in 30d · 1 in 90d
Politicians
10
Last trade Aug 26, 2026
Buys
12
$145K at range midpoints
Sells
10
$104.5K at range midpoints
Closing price · 365 days
Sep 24, 2025 – Sep 23, 2026
Monthly buys vs sells · 24 months
Counts of disclosed transactions
- Buys
- Sells (incl. partial)
Politicians who traded it
7 hold it now Estimated
| Politician | Seat | Trades | Buys | Sells | Bought (mid) | Sold (mid) | Last trade | Est. position Estimated |
|---|---|---|---|---|---|---|---|---|
| RByron Donalds | House · FL-19 | 4 | 2 | 2 | $16K | $16K | Mar 20, 2025 | $9.8K |
| RDavid J. Taylor | House · OH-02 | 3 | 1 | 2 | $8K | $16K | Aug 26, 2026 | — |
| RJefferson Shreve | House · IN-06 | 3 | 2 | 1 | $65K | $32.5K | May 12, 2025 | $30K |
| RLisa C. McClain | House · MI-09 | 3 | 1 | 2 | $8K | $16K | Jun 11, 2025 | — |
| RTommy Tuberville | Senate · AL | 3 | 1 | 2 | $8K | $16K | May 3, 2024 | — |
| DGreg Stanton | House · AZ-04 | 2 | 1 | 1 | $8K | $8K | Oct 24, 2023 | $563 |
| RAlan Armstrong | Senate · OK | 1 | 1 | 0 | $8K | $0 | Mar 27, 2026 | $9.5K |
| DDean Phillips | House · MN-03 | 1 | 1 | 0 | $8K | $0 | Dec 18, 2020 | $17.5K |
| RJulia Letlow | House · LA-05 | 1 | 1 | 0 | $8K | $0 | Oct 23, 2024 | $8.8K |
| DWilliam R. Keating | House · MA-09 | 1 | 1 | 0 | $8K | $0 | Mar 29, 2022 | $16K |
Recent trades
| Politician | Ticker | Asset | Type | Owner | Amount | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|
| RDavid J. Taylor | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Self | $1,001 - $15,000 | Aug 26, 2026 | Sep 5, 202610d | Filing |
| RTommy Tuberville | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | Sell | Joint | $1,001 - $15,000 | May 3, 2024 | Aug 5, 2026824d | Filing |
| RAlan Armstrong | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | Buy | Self | $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026116d | Filing |
| RDavid J. Taylor | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Self | $1,001 - $15,000 | Jan 29, 2026 | Feb 2, 20264d | Filing |
| RJulia Letlow | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Buy | Self | $1,001 - $15,000 | Oct 23, 2024 | Jan 13, 2026447d | Filing |
| RDavid J. Taylor | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Buy | Self | $1,001 - $15,000 | Aug 7, 2025 | Sep 2, 202526d | Filing |
| RLisa C. McClain | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Spouse | $1,001 - $15,000 | Jun 11, 2025 | Aug 13, 202563d | Filing |
| RLisa C. McClain | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Partial | Spouse | $1,001 - $15,000 | Jun 10, 2025 | Aug 13, 202564d | Filing |
| RLisa C. McClain | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Buy | Spouse | $1,001 - $15,000 | Dec 11, 2024 | Aug 13, 2025245d | Filing |
| RJefferson Shreve | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Self | $15,001 - $50,000 | May 12, 2025 | Jun 22, 202541d | Filing |
| RByron Donalds | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Spouse | $1,001 - $15,000 | Mar 20, 2025 | Apr 14, 202525d | Filing |
| RByron Donalds | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Sell | Self | $1,001 - $15,000 | Mar 20, 2025 | Apr 14, 202525d | Filing |
| RJefferson Shreve | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Buy | Self | $15,001 - $50,000 | Mar 13, 2025 | Apr 11, 202529d | Filing |
| RJefferson Shreve | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | Buy | Self | $15,001 - $50,000 | Feb 24, 2025 | Mar 9, 202513d | Filing |
| RByron Donalds | VRTX | Vertex Pharmaceuticals (VRTX) | BuyReview | Spouse | $1,001 - $15,000 | Dec 7, 2022 | Nov 8, 2024702d | FilingOCR |
| RByron Donalds | VRTX | Vertex Pharmaoeuticals (VRTX) | BuyReview | Self | $1,001 - $15,000 | Dec 7, 2022 | Nov 8, 2024702d | FilingOCR |
| RTommy Tuberville | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | Sell | Joint | $1,001 - $15,000 | May 3, 2024 | Jun 14, 202442d | Filing |
| DGreg Stanton | VRTX | Vertex Pharmaceuticals Incorporated (VRTX) | Sell | Spouse | $1,001 - $15,000 | Oct 24, 2023 | Nov 9, 202316d | Filing |
| DGreg Stanton | VRTX | Vertex Pharmaceuticals Incorporated (VRTX) | Buy | Spouse | $1,001 - $15,000 | Sep 26, 2023 | Nov 9, 202344d | Filing |
| RTommy Tuberville | VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | Buy | Joint | $1,001 - $15,000 | Oct 6, 2022 | Nov 10, 202235d | Filing |
| DWilliam R. Keating | VRTX | Vertex Pharmaceuticals Incorporated (VRTX) | Buy | Self | $1,001 - $15,000 | Mar 29, 2022 | May 5, 202237d | Filing |
| DDean Phillips | VRTX | Vertex Pharmaceuticals Incorporated (VRTX) | Buy | Self | $1,001 - $15,000 | Dec 18, 2020 | Jan 9, 202122d | Filing |
Insider activity Filed
Insiders
25
Pharmaceutical Preparations
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
4
$2.3M sold
Net · 90d
-$2.3M
-$158.4M net over 12 months · last Sep 8, 2026
| Date | Insider | Kind | Security | Shares | Price | Value | Post-holdings | D/I | 10b5-1 | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026filed Sep 10, 2026 | Jasper Van GrunsvenEVP, CP and NPPO | Award | Common Stock | 8,682 | $0.00 | $0 | 8,682 | D | — | 4 |
| Aug 28, 2026filed Sep 1, 2026 | Kristen AmbroseSVP & Chief Accounting Officer | Award | Common Stock | 5,000 | $0.00 | $0 | 11,624 | D | — | 4 |
| Aug 27, 2026filed Aug 31, 2026 | Bruce I Sachs | Gift | Common Stock | −6,000 | $0.00 | $0 | 39,000 | D | — | 4 |
| Jul 21, 2026filed Jul 23, 2026 | Ourania TatsisEVP, Chief Reg. & Quality Off. | Award | Common Stock | 8,251 | $0.00 | $0 | 53,572 | D | — | 4 |
| Jul 21, 2026filed Jul 23, 2026 | Amit SachdevEVP Chief Patient & Ext Af Off | Award | Common Stock | 8,251 | $0.00 | $0 | 66,512 | D | — | 4 |
| Jul 15, 2026filed Jul 17, 2026 | Bruce I Sachs | Award | Deferred Stock Unitsderiv. | 99.94 | $475.28 | — | 15,771.81 | D | — | 4 |
| Jul 15, 2026filed Jul 17, 2026 | Alan M Garber | Award | Deferred Stock Unitsderiv. | 31.56 | $475.28 | — | 65.46 | D | — | 4 |
| Jul 2, 2026filed Jul 7, 2026 | Ourania TatsisEVP, Chief Reg. & Quality Off. | Sale | Common Stock | −1,500 | $524.99 | $787,485 | 45,321 | D | 10b5-1 | 4 |
| Jul 2, 2026filed Jul 7, 2026 | Duncan McKechnieEVP, Chief Commercial Officer | Sale | Common Stock | −1,541 | $519.00 | $799,779 | 11,001 | D | 10b5-1 | 4 |
| Jul 1, 2026filed Jul 6, 2026 | Joy LiuEVP and Chief Legal Officer | Sale | Common Stock | −828 | $502.71 | $416,244 | 19,131 | D | 10b5-1 | 4 |
Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).
Unusual activity Estimated
- 65Insider overlapMar 27, 2026
Sen. Alan Armstrong bought VRTX 28 days after its CEO sold $7.7M
Details
- Politician
- Alan Armstrong
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock
- Tx type
- buy
- Tx date
- Mar 27, 2026
- Filing date
- Jul 21, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 116
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2026-02-27","shares":15580,"price":495.38,"value":7718020.4,"is_10b5_1":true}
- Days between
- 28
- Opposite side
- Yes
- 28Exec saleFeb 27, 2026
VRTX CEO Reshma Kewalramani sold $7.7M (10b5-1 plan)
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Feb 27, 2026
- Shares
- 15,580
- Price
- $495
- Value
- $7.7M
- Is 10b5 1
- Yes
- 50Insider overlapJan 29, 2026
Rep. David J. Taylor sold VRTX 29 days before its CEO sold $7.7M
Details
- Politician
- David J. Taylor
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
- Tx type
- sell
- Tx date
- Jan 29, 2026
- Filing date
- Feb 2, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 4
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_sale","tx_date":"2026-02-27","shares":15580,"price":495.38,"value":7718020.4,"is_10b5_1":true}
- Days between
- -29
- Opposite side
- No
- 27Exec saleDec 3, 2025
VRTX Chair Jeffrey M Leiden sold $7.1M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Dec 3, 2025
- Shares
- 15,681
- Price
- $452
- Value
- $7.1M
- Is 10b5 1
- Yes
- 32Exec saleNov 14, 2025
VRTX Chair Jeffrey M Leiden sold $14.2M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Nov 14, 2025
- Shares
- 32,234
- Price
- $440
- Value
- $14.2M
- Is 10b5 1
- Yes
- 29Exec saleNov 14, 2025
VRTX Chair Jeffrey M Leiden sold $9.4M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Nov 14, 2025
- Shares
- 21,330
- Price
- $441
- Value
- $9.4M
- Is 10b5 1
- Yes
- 28Exec saleNov 13, 2025
VRTX Chair Jeffrey M Leiden sold $8.2M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Nov 13, 2025
- Shares
- 18,528
- Price
- $440
- Value
- $8.2M
- Is 10b5 1
- Yes
- 50Insider overlapAug 7, 2025
Rep. David J. Taylor bought VRTX 1 day after its CEO bought $2.2M
Details
- Politician
- David J. Taylor
- Ticker
- VRTX
- Asset
- Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
- Tx type
- buy
- Tx date
- Aug 7, 2025
- Filing date
- Sep 2, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Amount mid
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 26
- Is whale
- No
- Insider trade
- {"insider":{"slug":"reshma-kewalramani","name":"Reshma Kewalramani","title":"CEO & President","short_title":"CEO"},"company":"VERTEX PHARMACEUTICALS INC / MA","ticker":"VRTX","tx_kind":"open_market_buy","tx_date":"2025-08-06","shares":5710,"price":389.95,"value":2226614.5,"is_10b5_1":false}
- Days between
- 1
- Opposite side
- No
- 65Exec buyAug 6, 2025
VRTX CEO Reshma Kewalramani bought $2.2M on the open market
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_buy
- Tx date
- Aug 6, 2025
- Shares
- 5,710
- Price
- $390
- Value
- $2.2M
- Is 10b5 1
- No
- 63Exec buyAug 6, 2025
VRTX CEO Reshma Kewalramani bought $1.7M on the open market
Details
- Insider
- Reshma Kewalramani
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_buy
- Tx date
- Aug 6, 2025
- Shares
- 4,290
- Price
- $389
- Value
- $1.7M
- Is 10b5 1
- No